Condition: Non-Proliferative Diabetic Retinopathy · Sponsor: Beletalent (Zhuhai) Pharmaceutical Co., Ltd
The goal of this clinical trial is to learn if drug TNTL works to treat non-proliferative diabetic retinopathy in adults. It will also learn about the safety of drug TNTL. The main questions it aims to answer are: 1. Does drug TNTL can improve visual acuity and reduce the degree of retinopathy? 2. What medical problems do participants have when taking drug TNTL? Researchers will compare drug TNTL to a placebo (a look-alike substance that contains no drug) to see if drug TNTL works to treat non-proliferative diabetic retinopathy. Participants will: 1. Take drug TNTL or a placebo every day for 6 months 2. Visit the clinic once every 4 weeks for checkups and tests 3. Keep a diary of their symptoms and Change from baseline
This description comes directly from the study's public registry record.
Jinxin Clinical Project Manager · +86 13885383954 · trade@beletalent.com
Always discuss trial participation with your own doctor first.
| Xuancheng People's Hospital | Xuancheng, Anhui, China | Recruiting |
| Beijing Chaoyang Hospital | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital of Guangzhou University of Chinese Medicine | Guangzhou, Guangdong, China | Recruiting |
| Shenzhen Eye Hospital | Shenzhen, Guangdong, China | Recruiting |
| Zhuhai People's Hospital | Zhuhai, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine | Guiyang, Guizhou, China | Recruiting |
| Guizhou Provincial People's Hospital | Guiyang, Guizhou, China | Recruiting |
| Shijiazhuang People's Hospital | Shijiazhuang, Hebei, China | Recruiting |
| Kaifeng Central Hospital | Kaifeng, Henan, China | Recruiting |
| Luoyang Third People's Hospital | Luoyang, Henan, China | Recruiting |
| Xinxiang Central Hospital | Xinxiang, Henan, China | Recruiting |
| People's Hospital of Zhengzhou | Zhengzhou, Henan, China | Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06817265